BSE filing, NSE: GUJALKALI. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Alkalies & Chemicals Ltd: key numbers
- Share price
- ₹559.00
- Market cap
- ₹4,105 Cr
- Revenue (annual)
- ₹4,358 Cr
- Net profit (annual)
- ₹-2.41 Cr
- P/E (TTM)
- 61.9×Sector 34.5×
- Promoter holding
- 47.28%+0.00% QoQ
- FII holding
- 3.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Alkalies & Chemicals Ltd
All →Gujarat Alkalies & Chemicals Capacity Expansion
GACL conducted the ground-breaking ceremony of its 33,870 TPA food-grade phosphoric acid plant PPA-II at Dahej. The facility marks the start of construction for capacity expansion.
- phosphoric acid production capacity
- 33870 TPA
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Limited has published newspaper advertisements regarding a special window for the transfer and dematerialization of physical securities as per SEBI regulations.
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Gujarat Alkalies & Chemicals Annual General Meeting
Gujarat Alkalies and Chemicals Limited conducted its 53rd Annual General Meeting on September 25, 2026. Members considered dividend declaration and approval of material related party transactions.
Gujarat Alkalies & Chemicals Business Update
Gujarat Alkalies and Chemicals Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational metrics.
Gujarat Alkalies & Chemicals Annual General Meeting
Gujarat Alkalies and Chemicals Limited has scheduled its 53rd Annual General Meeting for September 25, 2026. Key agenda items include dividend declaration and related party transaction approvals.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.